Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulforaphane for Cognitive Impairment in PD
NCT05084365Phase 2Unknown
- Sponsor
- Central South University
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulforaphane in Parkinson's disease (PD), sponsored by Central South University. Status: unknown.
02
Drugs
sulforaphane
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05084365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084365.